What did @jeh_jewel actually say?
Here is the honest answer: the transcript does not contain what the caption promises. The spoken words in this video are largely incoherent filler, repeating phrases like "we have seen many people who have been studying with us" without a single substantive claim about ipamorelin. The science is entirely in the caption, not in the creator's mouth.
The caption, however, makes two specific claims worth examining: that ipamorelin is "amplamente estudado na literatura científica" (widely studied in scientific literature) and that it works "respeitando o ritmo natural do corpo" (respecting the body's natural rhythm) "sem provocar picos artificiais" (without causing artificial peaks). Those are the claims we are fact-checking here, because they are the ones the audience is actually reading.
Does the science back this up?
Partially, and with important caveats. Ipamorelin is a synthetic pentapeptide that acts as a selective growth hormone secretagogue, binding to the ghrelin receptor (GHSR-1a) to stimulate pulsatile GH release. There is real science here, but "widely studied" is a stretch.
Most ipamorelin research consists of preclinical animal studies and a limited number of small human trials. A 1999 study by Raun et al. in the European Journal of Endocrinology confirmed ipamorelin's selectivity for GH release over cortisol and prolactin in rats, which is where the "natural rhythm" framing originates. Human pharmacokinetic data remains thin. A 2008 Phase II trial by Corpak MedSystems examined ipamorelin for postoperative ileus, but results were not conclusive enough to bring the compound to market. Calling this body of evidence "widely studied" gives the impression of a robust clinical literature that simply does not yet exist for humans.
What did they get wrong (or right)?
The "pulsatile, non-spiking" framing is mostly accurate in its mechanism, and I will give credit for that. Ipamorelin does produce more physiologically patterned GH pulses compared to direct GH injections or some other secretagogues like GHRP-6, which also stimulates cortisol and prolactin at higher doses. Raun et al. (1999) specifically noted ipamorelin's selectivity as a distinguishing characteristic.
What they got wrong, or at least oversimplified:
- "Widely studied" overstates the human evidence base. Most data is preclinical.
- Framing pulsatile release as inherently safe or natural for all users ignores that exogenous GH secretagogues still suppress endogenous signaling pathways over time, a concern documented in long-term secretagogue use reviews (Walker, 2006, Current Opinion in Clinical Nutrition and Metabolic Care).
- The transcript itself contains no actual educational content, which raises questions about what "educação em saúde" is actually being delivered here.
What should you actually know?
Ipamorelin is not approved by any major regulatory agency, including ANVISA in Brazil, as a therapeutic drug for humans. It exists in a gray zone: studied, discussed, and used off-label, but without the clinical trial data required to call it proven for any specific human outcome.
The "respects your body's rhythm" framing is a marketing frame built on real but incomplete science. Pulsatile GH release is indeed how the body normally operates, and ipamorelin mimics that pattern more closely than synthetic GH. But mimicking a pattern does not mean the intervention is without risk, especially for women, whose GH axis is significantly more complex and cycle-dependent than in male study populations. If you are considering any peptide therapy, that conversation needs to happen with a licensed clinician who has access to your full health picture, not through a TikTok caption.
The bottom line
The caption's core mechanistic claim about ipamorelin and pulsatile GH release is directionally correct but overstated. The video itself delivers no actual information. The hashtag "educacaemsaude" implies health education is happening. Based on the transcript, it is not.